Dexcom: Anyone else feeling unease about stability?

Lately, there's been this undercurrent of uncertainty that I can't quite shake. It's not one specific thing, but a collection of small signs. You know, the usual 'things that make you go hmmm'. Heard a few whispers, saw some internal reorganizations that seemed a bit more than routine. The market's been tough for MedTech lately, and while Dexcom is a strong player, nobody's completely immune. I'm trying not to jump to conclusions, but I'm wondering if anyone else is picking up on similar vibes. Are there any teams feeling the squeeze more than others? Any new hires being put on hold, or projects being reassessed? Just looking to see if others are feeling this quiet tension or if I'm just overthinking things based on external factors. Sharing thoughts, not making accusations. Stay safe out there.